Trial Profile
A randomised, double-blinded, comparative study of 10 and 20mg dexrabeprazole daily in patients with gastroesophageal reflux disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Apr 2014
Price :
$35
*
At a glance
- Drugs Dexrabeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 10 Apr 2014 New trial record